🔎 Trials Near Me

Home › Lung Diseases › Indiana › Indianapolis

Lung Diseases clinical trials in Indianapolis, IN

5 studies for Lung Diseases are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

RecruitingPhase 2
  • Indiana University Health University Hospital, Indianapolis
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecruitingPhase 1/2
  • Community Health Network, Indianapolis
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RecruitingPhase 3
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
  • Community Cancer Center North, Indianapolis
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Recruiting
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT02984761

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

Recruiting
  • St. Vincent Health, Indianapolis
Ages 18 and older · All sexes · Updated Sep 29, 2025 · NCT04555161

About Lung Diseases

Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.

More about Lung Diseases on MedlinePlus

Lung Diseases trials in other cities

Other studies in Indianapolis

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.